Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Dec 1;64(12):6201-6212.
doi: 10.1093/rheumatology/keaf424.

Decreasing prevalence and cumulative incidence of scleroderma renal crisis over time: associated factors identified from the RESCLE registry

Xavier Pla-Salas  1   2 , Carles Tolosa-Vilella  3 , Maria Baldà-Masmiquel  4 , Alfredo Guillén-Del-Castillo  5 , Manuel Rubio-Rivas  6 , Ana Argibay-Filgueira  7 , Adela Marín-Ballvé  8 , Ignasi Rodríguez-Pintó  9 , Eduardo Callejas-Moraga  3 , Dolores Colunga-Argüelles  10 , Luís Sáez-Comet  11 , Cristina González-de-Echávarri  12 , Norberto Ortego-Centeno  13   14 , Begoña Marí-Alonso  3 , Jose Antonio Vargas-Hitos  15 , Jose Antonio Todolí-Parra  16 , Luís Trapiella-Martínez  10 , Maria Teresa Herranz-Marín  17 , Mayka Freire  18 , Antoni Castro-Salomó  19 , Isabel Perales-Fraile  20 , Ana Belén Madroñero-Vuelta  21 , Maria Esther Sánchez-García  22 , Andrés González-García  23 , Jorge Sánchez-Redondo  24 , Glória De-la-Red  25 , Alejandra Fernández-Luque  26 , A Muela-Molinero  27 , Gemma Lledó  28 , Antonio Javier Chamorro-Fernández  29 , Mónica Rodríguez-Carballeira  9 , Sabela Sánchez-Trigo  30 , Rafael Ángel Fernández-de-la-Puebla  31 , Isaac Pons-Martín-Del-Campo  1   2 , Vincent Fonollosa-Pla  5 , Carmen Pilar Simeón-Aznar  5 ; RESCLE Investigators
Collaborators, Affiliations

Decreasing prevalence and cumulative incidence of scleroderma renal crisis over time: associated factors identified from the RESCLE registry

Xavier Pla-Salas et al. Rheumatology (Oxford). .

Abstract

Objectives: To determine the prevalence and incidence of scleroderma renal crisis (SRC) in patients with SSc over two time periods and to identify factors influencing potential epidemiological changes.

Methods: A total of 1939 SSc patients were categorized based on their diagnostic date. The 'historical cohort' (HC) included patients diagnosed before 31 December 2002, while the 'contemporary cohort' (CC) included those diagnosed afterwards. Epidemiological differences in SRC between both cohorts were investigated in the overall SSc series, and according to cutaneous subsets and antibody profile. If differences were present, the factors involved were assessed.

Results: Forty-four patients developed SRC (prevalence rate: 2.3%), first-year incidence: 2.09 events per 100 person-years. Patients with diffuse cutaneous subset (dcSSc) (8.1%), anti-RNA polymerase III positive antibodies (12.0%) or anti-topo I positive antibodies (4.3%) had a higher prevalence of SRC than those with limited cutaneous subset (lcSSc) (0.9%) or anti-centromere-positive antibodies (0.7%). SRC prevalence decreased over time (HC vs CC) in the overall SSc series (3.7% vs 1.3%; P = 0.001), definite-SSc cohort (3.9% vs 1.4%; P = 0.002) and lcSSc (1.8% vs 0.3%; P = 0.013), but not in dcSSc or by antibody profile. Factors independently associated with the CC included older age at SSc diagnosis, increased prevalence of early SSc and very early SSc subsets, tobacco exposure and higher medication use of calcium channel blockers, renin-angiotensin-aldosterone system inhibitors, specific vasodilators and immunosuppressants.

Conclusions: This study provides compelling evidence of a significant decline in SRC prevalence and cumulative incidence over time in SSc patients, particularly in definite-SSc patients and lcSSc patients. Factors associated with the CC are described.

Keywords: epidemiology; incidence; prevalence; scleroderma renal crisis.

PubMed Disclaimer